Global Anti-Migraine Drugs Market Growth 2023-2028

Report ID: 1210468 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Anti-Migraine Drugs Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Anti-Migraine Drugs by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Anti-Migraine Drugs by Country/Region, 2017, 2022 & 2028
    2.2 Anti-Migraine Drugs Segment by Type
        2.2.1 Triptans
        2.2.2 Ergots
        2.2.3 Others
    2.3 Anti-Migraine Drugs Sales by Type
        2.3.1 Global Anti-Migraine Drugs Sales Market Share by Type (2017-2022)
        2.3.2 Global Anti-Migraine Drugs Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Anti-Migraine Drugs Sale Price by Type (2017-2022)
    2.4 Anti-Migraine Drugs Segment by Application
        2.4.1 Women
        2.4.2 Men
    2.5 Anti-Migraine Drugs Sales by Application
        2.5.1 Global Anti-Migraine Drugs Sale Market Share by Application (2017-2022)
        2.5.2 Global Anti-Migraine Drugs Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Anti-Migraine Drugs Sale Price by Application (2017-2022)
3 Global Anti-Migraine Drugs by Company
    3.1 Global Anti-Migraine Drugs Breakdown Data by Company
        3.1.1 Global Anti-Migraine Drugs Annual Sales by Company (2020-2022)
        3.1.2 Global Anti-Migraine Drugs Sales Market Share by Company (2020-2022)
    3.2 Global Anti-Migraine Drugs Annual Revenue by Company (2020-2022)
        3.2.1 Global Anti-Migraine Drugs Revenue by Company (2020-2022)
        3.2.2 Global Anti-Migraine Drugs Revenue Market Share by Company (2020-2022)
    3.3 Global Anti-Migraine Drugs Sale Price by Company
    3.4 Key Manufacturers Anti-Migraine Drugs Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Anti-Migraine Drugs Product Location Distribution
        3.4.2 Players Anti-Migraine Drugs Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-Migraine Drugs by Geographic Region
    4.1 World Historic Anti-Migraine Drugs Market Size by Geographic Region (2017-2022)
        4.1.1 Global Anti-Migraine Drugs Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Anti-Migraine Drugs Annual Revenue by Geographic Region
    4.2 World Historic Anti-Migraine Drugs Market Size by Country/Region (2017-2022)
        4.2.1 Global Anti-Migraine Drugs Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Anti-Migraine Drugs Annual Revenue by Country/Region
    4.3 Americas Anti-Migraine Drugs Sales Growth
    4.4 APAC Anti-Migraine Drugs Sales Growth
    4.5 Europe Anti-Migraine Drugs Sales Growth
    4.6 Middle East & Africa Anti-Migraine Drugs Sales Growth
5 Americas
    5.1 Americas Anti-Migraine Drugs Sales by Country
        5.1.1 Americas Anti-Migraine Drugs Sales by Country (2017-2022)
        5.1.2 Americas Anti-Migraine Drugs Revenue by Country (2017-2022)
    5.2 Americas Anti-Migraine Drugs Sales by Type
    5.3 Americas Anti-Migraine Drugs Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Anti-Migraine Drugs Sales by Region
        6.1.1 APAC Anti-Migraine Drugs Sales by Region (2017-2022)
        6.1.2 APAC Anti-Migraine Drugs Revenue by Region (2017-2022)
    6.2 APAC Anti-Migraine Drugs Sales by Type
    6.3 APAC Anti-Migraine Drugs Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Anti-Migraine Drugs by Country
        7.1.1 Europe Anti-Migraine Drugs Sales by Country (2017-2022)
        7.1.2 Europe Anti-Migraine Drugs Revenue by Country (2017-2022)
    7.2 Europe Anti-Migraine Drugs Sales by Type
    7.3 Europe Anti-Migraine Drugs Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Anti-Migraine Drugs by Country
        8.1.1 Middle East & Africa Anti-Migraine Drugs Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Anti-Migraine Drugs Revenue by Country (2017-2022)
    8.2 Middle East & Africa Anti-Migraine Drugs Sales by Type
    8.3 Middle East & Africa Anti-Migraine Drugs Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Anti-Migraine Drugs
    10.3 Manufacturing Process Analysis of Anti-Migraine Drugs
    10.4 Industry Chain Structure of Anti-Migraine Drugs
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Anti-Migraine Drugs Distributors
    11.3 Anti-Migraine Drugs Customer
12 World Forecast Review for Anti-Migraine Drugs by Geographic Region
    12.1 Global Anti-Migraine Drugs Market Size Forecast by Region
        12.1.1 Global Anti-Migraine Drugs Forecast by Region (2023-2028)
        12.1.2 Global Anti-Migraine Drugs Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Anti-Migraine Drugs Forecast by Type
    12.7 Global Anti-Migraine Drugs Forecast by Application
13 Key Players Analysis
    13.1 Eli Lilly
        13.1.1 Eli Lilly Company Information
        13.1.2 Eli Lilly Anti-Migraine Drugs Product Offered
        13.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Eli Lilly Main Business Overview
        13.1.5 Eli Lilly Latest Developments
    13.2 Abbott
        13.2.1 Abbott Company Information
        13.2.2 Abbott Anti-Migraine Drugs Product Offered
        13.2.3 Abbott Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Abbott Main Business Overview
        13.2.5 Abbott Latest Developments
    13.3 Eisai
        13.3.1 Eisai Company Information
        13.3.2 Eisai Anti-Migraine Drugs Product Offered
        13.3.3 Eisai Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Eisai Main Business Overview
        13.3.5 Eisai Latest Developments
    13.4 Allergan
        13.4.1 Allergan Company Information
        13.4.2 Allergan Anti-Migraine Drugs Product Offered
        13.4.3 Allergan Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Allergan Main Business Overview
        13.4.5 Allergan Latest Developments
    13.5 Endo
        13.5.1 Endo Company Information
        13.5.2 Endo Anti-Migraine Drugs Product Offered
        13.5.3 Endo Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Endo Main Business Overview
        13.5.5 Endo Latest Developments
    13.6 GlaxoSmithKline
        13.6.1 GlaxoSmithKline Company Information
        13.6.2 GlaxoSmithKline Anti-Migraine Drugs Product Offered
        13.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 GlaxoSmithKline Main Business Overview
        13.6.5 GlaxoSmithKline Latest Developments
    13.7 Impax Laboratories
        13.7.1 Impax Laboratories Company Information
        13.7.2 Impax Laboratories Anti-Migraine Drugs Product Offered
        13.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Impax Laboratories Main Business Overview
        13.7.5 Impax Laboratories Latest Developments
    13.8 Pfizer
        13.8.1 Pfizer Company Information
        13.8.2 Pfizer Anti-Migraine Drugs Product Offered
        13.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Pfizer Main Business Overview
        13.8.5 Pfizer Latest Developments
    13.9 AstraZeneca
        13.9.1 AstraZeneca Company Information
        13.9.2 AstraZeneca Anti-Migraine Drugs Product Offered
        13.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 AstraZeneca Main Business Overview
        13.9.5 AstraZeneca Latest Developments
    13.10 Bayer
        13.10.1 Bayer Company Information
        13.10.2 Bayer Anti-Migraine Drugs Product Offered
        13.10.3 Bayer Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Bayer Main Business Overview
        13.10.5 Bayer Latest Developments
    13.11 Johnson & Johnson
        13.11.1 Johnson & Johnson Company Information
        13.11.2 Johnson & Johnson Anti-Migraine Drugs Product Offered
        13.11.3 Johnson & Johnson Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Johnson & Johnson Main Business Overview
        13.11.5 Johnson & Johnson Latest Developments
    13.12 Merck
        13.12.1 Merck Company Information
        13.12.2 Merck Anti-Migraine Drugs Product Offered
        13.12.3 Merck Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Merck Main Business Overview
        13.12.5 Merck Latest Developments
    13.13 Teva
        13.13.1 Teva Company Information
        13.13.2 Teva Anti-Migraine Drugs Product Offered
        13.13.3 Teva Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Teva Main Business Overview
        13.13.5 Teva Latest Developments
    13.14 Amgen
        13.14.1 Amgen Company Information
        13.14.2 Amgen Anti-Migraine Drugs Product Offered
        13.14.3 Amgen Anti-Migraine Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Amgen Main Business Overview
        13.14.5 Amgen Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Anti-Migraine Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Anti-Migraine Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Triptans
    Table 4. Major Players of Ergots
    Table 5. Major Players of Others
    Table 6. Global Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
    Table 7. Global Anti-Migraine Drugs Sales Market Share by Type (2017-2022)
    Table 8. Global Anti-Migraine Drugs Revenue by Type (2017-2022) & ($ million)
    Table 9. Global Anti-Migraine Drugs Revenue Market Share by Type (2017-2022)
    Table 10. Global Anti-Migraine Drugs Sale Price by Type (2017-2022) & (USD/Pcs)
    Table 11. Global Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
    Table 12. Global Anti-Migraine Drugs Sales Market Share by Application (2017-2022)
    Table 13. Global Anti-Migraine Drugs Revenue by Application (2017-2022)
    Table 14. Global Anti-Migraine Drugs Revenue Market Share by Application (2017-2022)
    Table 15. Global Anti-Migraine Drugs Sale Price by Application (2017-2022) & (USD/Pcs)
    Table 16. Global Anti-Migraine Drugs Sales by Company (2020-2022) & (K Units)
    Table 17. Global Anti-Migraine Drugs Sales Market Share by Company (2020-2022)
    Table 18. Global Anti-Migraine Drugs Revenue by Company (2020-2022) ($ Millions)
    Table 19. Global Anti-Migraine Drugs Revenue Market Share by Company (2020-2022)
    Table 20. Global Anti-Migraine Drugs Sale Price by Company (2020-2022) & (USD/Pcs)
    Table 21. Key Manufacturers Anti-Migraine Drugs Producing Area Distribution and Sales Area
    Table 22. Players Anti-Migraine Drugs Products Offered
    Table 23. Anti-Migraine Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global Anti-Migraine Drugs Sales by Geographic Region (2017-2022) & (K Units)
    Table 27. Global Anti-Migraine Drugs Sales Market Share Geographic Region (2017-2022)
    Table 28. Global Anti-Migraine Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 29. Global Anti-Migraine Drugs Revenue Market Share by Geographic Region (2017-2022)
    Table 30. Global Anti-Migraine Drugs Sales by Country/Region (2017-2022) & (K Units)
    Table 31. Global Anti-Migraine Drugs Sales Market Share by Country/Region (2017-2022)
    Table 32. Global Anti-Migraine Drugs Revenue by Country/Region (2017-2022) & ($ millions)
    Table 33. Global Anti-Migraine Drugs Revenue Market Share by Country/Region (2017-2022)
    Table 34. Americas Anti-Migraine Drugs Sales by Country (2017-2022) & (K Units)
    Table 35. Americas Anti-Migraine Drugs Sales Market Share by Country (2017-2022)
    Table 36. Americas Anti-Migraine Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 37. Americas Anti-Migraine Drugs Revenue Market Share by Country (2017-2022)
    Table 38. Americas Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
    Table 39. Americas Anti-Migraine Drugs Sales Market Share by Type (2017-2022)
    Table 40. Americas Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
    Table 41. Americas Anti-Migraine Drugs Sales Market Share by Application (2017-2022)
    Table 42. APAC Anti-Migraine Drugs Sales by Region (2017-2022) & (K Units)
    Table 43. APAC Anti-Migraine Drugs Sales Market Share by Region (2017-2022)
    Table 44. APAC Anti-Migraine Drugs Revenue by Region (2017-2022) & ($ Millions)
    Table 45. APAC Anti-Migraine Drugs Revenue Market Share by Region (2017-2022)
    Table 46. APAC Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
    Table 47. APAC Anti-Migraine Drugs Sales Market Share by Type (2017-2022)
    Table 48. APAC Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
    Table 49. APAC Anti-Migraine Drugs Sales Market Share by Application (2017-2022)
    Table 50. Europe Anti-Migraine Drugs Sales by Country (2017-2022) & (K Units)
    Table 51. Europe Anti-Migraine Drugs Sales Market Share by Country (2017-2022)
    Table 52. Europe Anti-Migraine Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 53. Europe Anti-Migraine Drugs Revenue Market Share by Country (2017-2022)
    Table 54. Europe Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
    Table 55. Europe Anti-Migraine Drugs Sales Market Share by Type (2017-2022)
    Table 56. Europe Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
    Table 57. Europe Anti-Migraine Drugs Sales Market Share by Application (2017-2022)
    Table 58. Middle East & Africa Anti-Migraine Drugs Sales by Country (2017-2022) & (K Units)
    Table 59. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Country (2017-2022)
    Table 60. Middle East & Africa Anti-Migraine Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 61. Middle East & Africa Anti-Migraine Drugs Revenue Market Share by Country (2017-2022)
    Table 62. Middle East & Africa Anti-Migraine Drugs Sales by Type (2017-2022) & (K Units)
    Table 63. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Type (2017-2022)
    Table 64. Middle East & Africa Anti-Migraine Drugs Sales by Application (2017-2022) & (K Units)
    Table 65. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Application (2017-2022)
    Table 66. Key Market Drivers & Growth Opportunities of Anti-Migraine Drugs
    Table 67. Key Market Challenges & Risks of Anti-Migraine Drugs
    Table 68. Key Industry Trends of Anti-Migraine Drugs
    Table 69. Anti-Migraine Drugs Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. Anti-Migraine Drugs Distributors List
    Table 72. Anti-Migraine Drugs Customer List
    Table 73. Global Anti-Migraine Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 74. Global Anti-Migraine Drugs Sales Market Forecast by Region
    Table 75. Global Anti-Migraine Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 76. Global Anti-Migraine Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 77. Americas Anti-Migraine Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 78. Americas Anti-Migraine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 79. APAC Anti-Migraine Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 80. APAC Anti-Migraine Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 81. Europe Anti-Migraine Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 82. Europe Anti-Migraine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 83. Middle East & Africa Anti-Migraine Drugs Sales Forecast by Country (2023-2028) & (K Units)
    Table 84. Middle East & Africa Anti-Migraine Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Global Anti-Migraine Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 86. Global Anti-Migraine Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 87. Global Anti-Migraine Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 88. Global Anti-Migraine Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 89. Global Anti-Migraine Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 90. Global Anti-Migraine Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 91. Global Anti-Migraine Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 92. Global Anti-Migraine Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 93. Eli Lilly Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 94. Eli Lilly Anti-Migraine Drugs Product Offered
    Table 95. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 96. Eli Lilly Main Business
    Table 97. Eli Lilly Latest Developments
    Table 98. Abbott Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 99. Abbott Anti-Migraine Drugs Product Offered
    Table 100. Abbott Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 101. Abbott Main Business
    Table 102. Abbott Latest Developments
    Table 103. Eisai Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 104. Eisai Anti-Migraine Drugs Product Offered
    Table 105. Eisai Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 106. Eisai Main Business
    Table 107. Eisai Latest Developments
    Table 108. Allergan Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 109. Allergan Anti-Migraine Drugs Product Offered
    Table 110. Allergan Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 111. Allergan Main Business
    Table 112. Allergan Latest Developments
    Table 113. Endo Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 114. Endo Anti-Migraine Drugs Product Offered
    Table 115. Endo Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 116. Endo Main Business
    Table 117. Endo Latest Developments
    Table 118. GlaxoSmithKline Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 119. GlaxoSmithKline Anti-Migraine Drugs Product Offered
    Table 120. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 121. GlaxoSmithKline Main Business
    Table 122. GlaxoSmithKline Latest Developments
    Table 123. Impax Laboratories Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 124. Impax Laboratories Anti-Migraine Drugs Product Offered
    Table 125. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 126. Impax Laboratories Main Business
    Table 127. Impax Laboratories Latest Developments
    Table 128. Pfizer Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 129. Pfizer Anti-Migraine Drugs Product Offered
    Table 130. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 131. Pfizer Main Business
    Table 132. Pfizer Latest Developments
    Table 133. AstraZeneca Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 134. AstraZeneca Anti-Migraine Drugs Product Offered
    Table 135. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 136. AstraZeneca Main Business
    Table 137. AstraZeneca Latest Developments
    Table 138. Bayer Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 139. Bayer Anti-Migraine Drugs Product Offered
    Table 140. Bayer Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 141. Bayer Main Business
    Table 142. Bayer Latest Developments
    Table 143. Johnson & Johnson Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 144. Johnson & Johnson Anti-Migraine Drugs Product Offered
    Table 145. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 146. Johnson & Johnson Main Business
    Table 147. Johnson & Johnson Latest Developments
    Table 148. Merck Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 149. Merck Anti-Migraine Drugs Product Offered
    Table 150. Merck Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 151. Merck Main Business
    Table 152. Merck Latest Developments
    Table 153. Teva Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 154. Teva Anti-Migraine Drugs Product Offered
    Table 155. Teva Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 156. Teva Main Business
    Table 157. Teva Latest Developments
    Table 158. Amgen Basic Information, Anti-Migraine Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 159. Amgen Anti-Migraine Drugs Product Offered
    Table 160. Amgen Anti-Migraine Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 161. Amgen Main Business
    Table 162. Amgen Latest Developments
List of Figures
    Figure 1. Picture of Anti-Migraine Drugs
    Figure 2. Anti-Migraine Drugs Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Anti-Migraine Drugs Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Anti-Migraine Drugs Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Anti-Migraine Drugs Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Triptans
    Figure 10. Product Picture of Ergots
    Figure 11. Product Picture of Others
    Figure 12. Global Anti-Migraine Drugs Sales Market Share by Type in 2021
    Figure 13. Global Anti-Migraine Drugs Revenue Market Share by Type (2017-2022)
    Figure 14. Anti-Migraine Drugs Consumed in Women
    Figure 15. Global Anti-Migraine Drugs Market: Women (2017-2022) & (K Units)
    Figure 16. Anti-Migraine Drugs Consumed in Men
    Figure 17. Global Anti-Migraine Drugs Market: Men (2017-2022) & (K Units)
    Figure 18. Global Anti-Migraine Drugs Sales Market Share by Application (2017-2022)
    Figure 19. Global Anti-Migraine Drugs Revenue Market Share by Application in 2021
    Figure 20. Anti-Migraine Drugs Revenue Market by Company in 2021 ($ Million)
    Figure 21. Global Anti-Migraine Drugs Revenue Market Share by Company in 2021
    Figure 22. Global Anti-Migraine Drugs Sales Market Share by Geographic Region (2017-2022)
    Figure 23. Global Anti-Migraine Drugs Revenue Market Share by Geographic Region in 2021
    Figure 24. Global Anti-Migraine Drugs Sales Market Share by Region (2017-2022)
    Figure 25. Global Anti-Migraine Drugs Revenue Market Share by Country/Region in 2021
    Figure 26. Americas Anti-Migraine Drugs Sales 2017-2022 (K Units)
    Figure 27. Americas Anti-Migraine Drugs Revenue 2017-2022 ($ Millions)
    Figure 28. APAC Anti-Migraine Drugs Sales 2017-2022 (K Units)
    Figure 29. APAC Anti-Migraine Drugs Revenue 2017-2022 ($ Millions)
    Figure 30. Europe Anti-Migraine Drugs Sales 2017-2022 (K Units)
    Figure 31. Europe Anti-Migraine Drugs Revenue 2017-2022 ($ Millions)
    Figure 32. Middle East & Africa Anti-Migraine Drugs Sales 2017-2022 (K Units)
    Figure 33. Middle East & Africa Anti-Migraine Drugs Revenue 2017-2022 ($ Millions)
    Figure 34. Americas Anti-Migraine Drugs Sales Market Share by Country in 2021
    Figure 35. Americas Anti-Migraine Drugs Revenue Market Share by Country in 2021
    Figure 36. United States Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 37. Canada Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Mexico Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Brazil Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 40. APAC Anti-Migraine Drugs Sales Market Share by Region in 2021
    Figure 41. APAC Anti-Migraine Drugs Revenue Market Share by Regions in 2021
    Figure 42. China Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Japan Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 44. South Korea Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 45. Southeast Asia Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 46. India Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Australia Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Europe Anti-Migraine Drugs Sales Market Share by Country in 2021
    Figure 49. Europe Anti-Migraine Drugs Revenue Market Share by Country in 2021
    Figure 50. Germany Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 51. France Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 52. UK Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Italy Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Russia Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Middle East & Africa Anti-Migraine Drugs Sales Market Share by Country in 2021
    Figure 56. Middle East & Africa Anti-Migraine Drugs Revenue Market Share by Country in 2021
    Figure 57. Egypt Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 58. South Africa Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Israel Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Turkey Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 61. GCC Country Anti-Migraine Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Manufacturing Cost Structure Analysis of Anti-Migraine Drugs in 2021
    Figure 63. Manufacturing Process Analysis of Anti-Migraine Drugs
    Figure 64. Industry Chain Structure of Anti-Migraine Drugs
    Figure 65. Channels of Distribution
    Figure 66. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Anti-Migraine Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Anti-Migraine Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Anti-Migraine Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports